Epigral Limited, a leading chloro alkali manufacturer, announced its unaudited financial results for the third quarter and nine months ended December 31, 2025. The company's Board of Directors approved the results at a meeting held on January 30, 2026, showing a challenging quarter with revenue and profitability pressures.

Financial Performance Overview

The company's operational performance reflected mixed trends across key metrics during the quarter:

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Epigral's performance showed year-over-year decline in key financial parameters:

Operational Metrics and Cost Structure

The company's cost structure revealed several notable changes during Q3 FY26. Cost of materials consumed increased to ₹413.45 crore from ₹329.07 crore in the corresponding quarter of the previous year. However, the company benefited from favorable inventory changes, with a positive impact of ₹55.32 crore compared to an adverse impact of ₹3.68 crore in Q3 FY25.

Employee benefits expense rose to ₹31.61 crore from ₹29.09 crore year-over-year, while power and fuel expenses increased significantly to ₹42.37 crore from ₹30.78 crore in Q3 FY25. Depreciation and amortization expense climbed to ₹42.75 crore compared to ₹32.91 crore in the previous year's corresponding quarter.

Tax Benefits and Strategic Investments

A significant development during the period was Epigral's adoption of the reduced tax rate under Section 115BAA of the Income Tax Act, 1961. This resulted in a one-time deferred tax credit of ₹80.87 crore, which was recognized in the Statement of Profit and Loss for the quarter ended June 30, 2025.

The company continued its strategic investment in renewable energy through its partnership with Pro-Zeal Green Power Ten Private Limited. During the quarter ended September 30, 2025, Epigral invested ₹0.13 crore in equity share capital and ₹2.13 crore in Non-cumulative Optionally Convertible Debentures of the power producer, which is developing a 19.80 MW Wind Solar Hybrid Power plant in Gujarat.

Business Segment and Regulatory Updates

Epigral operates primarily in the chloro alkali and its derivatives segment, with sales substantially in the domestic market. The company's business activities fall within a single reportable segment as per Indian Accounting Standards.

The company has assessed the impact of the four Labour Codes notified by the Government of India on November 21, 2025, which consolidate 29 existing labour laws. The incremental liability for employees has been disclosed under employee benefit expenses, though the impact is not material to the financial results.

Consolidated Results

The consolidated financial results, which include associates ReNew Green (GJS Three) Private Limited and Pro-Zeal Green Power Ten Private Limited, showed similar trends. Consolidated net profit for Q3 FY26 stood at ₹39.11 crore compared to ₹103.63 crore in Q3 FY25, while nine-month consolidated net profit was ₹251.02 crore against ₹270.80 crore in the corresponding period of the previous year.

Epigral Limited has announced a conference call to discuss its Q3FY26 financial results, scheduled for Friday, January 30, 2026, at 5:00 PM IST. The company has formally notified both the National Stock Exchange of India Limited and BSE Limited about this upcoming investor interaction.

Regulatory Compliance and Notification

The company submitted the conference call intimation on January 23, 2026, in compliance with Regulation 30 and Para (A) of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Gaurang Trivedi (M. No. - A22307) signed the formal notification to the stock exchanges.

Management Participation

The Q3FY26 results discussion will feature key members of Epigral Limited's senior management team:

• Maulik Patel – Chairman and Managing Director
• Kaushal Soparkar – Executive Director
• Rakesh Agrawal – Chief Financial Officer
• Milind Kotecha – Investor Relations and Strategy

Conference Call Details

Emkay Global Financial Services Ltd is facilitating the conference call with comprehensive access arrangements for participants:

International Dial-in Access

The conference call provides extensive international toll-free access across multiple countries including Argentina, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Japan, Netherlands, Poland, Singapore, South Korea, Sweden, Thailand, UK, and USA. Each country has dedicated toll-free numbers for seamless participation.

Contact Information

For additional information regarding the conference call, participants can contact Meet Vora at meet.vora@emkayglobal.com or call +91 22 6624 2474. The company encourages pre-registration to avoid wait times and enable express joining through the DiamondPass™ feature.